Cytokeratin 19 Antikörper (Middle Region)
Kurzübersicht für Cytokeratin 19 Antikörper (Middle Region) (ABIN2776961)
Target
Alle Cytokeratin 19 (KRT19) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR
-
Homologie
- Cow: 86%, Dog: 100%, Goat: 77%, Guinea Pig: 85%, Horse: 100%, Human: 100%, Mouse: 92%, Pig: 93%, Rabbit: 100%, Rat: 93%, Sheep: 77%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against KRT19. It was validated on Western Blot.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of Human KRT19
-
-
anti-Keratin 19 (KRT19) antibody
KRT19 Reaktivität: Human WB, ELISA, IHC (p), ICC, IP, ICFC Wirt: Maus Monoclonal A53-B-A2 unconjugated
anti-Keratin 19 (KRT19) (AA 245-391) antibodyKRT19 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 1-403) antibodyKRT19 Reaktivität: Maus WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 127-322) antibodyKRT19 Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal C1 unconjugated
anti-Keratin 19 (KRT19) (AA 245-391) antibodyKRT19 Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal D1 unconjugated
anti-Keratin 19 (KRT19) antibodyKRT19 Reaktivität: Human, Maus, Ratte WB, IHC, FACS, IF Wirt: Maus Monoclonal KRT19-800 unconjugated
anti-Keratin 19 (KRT19) antibodyKRT19 Reaktivität: Human WB, IHC, FACS, IF Wirt: Maus Monoclonal KRT19-799 unconjugated
anti-Keratin 19 (KRT19) (AA 274-400) antibodyKRT19 Reaktivität: Human WB, IHC, ELISA Wirt: Maus Monoclonal 8H1A8 unconjugated
anti-Keratin 19 (KRT19) (AA 80-400) antibodyKRT19 Reaktivität: Human, Ratte WB, IHC, FACS, ELISA Wirt: Maus Monoclonal 2A1G9 unconjugated
anti-Keratin 19 (KRT19) (AA 241-400) antibodyKRT19 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Andere Bezeichnung
- KRT19
-
Hintergrund
-
KRT19 involved in the organization of myofibers. Together with KRT8, KRT19 helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Alias Symbols: CK19, K19, K1CS
Protein Interaction Partner: CEP57L1, PPP1R18, HAUS1, IKZF3, POLR1C, EIF4E2, UBE2I, KRT19, KRT2, KIFC3, FAM124B, CARD9, CCDC146, EIF4ENIF1, C1orf109, AMOTL2, TBC1D7, TFPT, UBC, MDM2, EED, KDM1A, BAG3, PAN2, VCAM1, ITGA4, FN1, EIF4A3, MAGOH, GRB2, CRK, SUMO1, SUMO2, SUMO3, UCHL5, POU5
Protein Size: 400 -
Molekulargewicht
- 44 kDa
-
Gen-ID
- 3880
-
NCBI Accession
- NM_002276, NP_002267
-
UniProt
- P08727
Target
-
